Journal article · 2023

Abstract B055: Characterization of highly selective and CNS-penetrant PARP1 inhibitors

Phillip M. Cowley, Barry E. McGuinness, Gillian M. Campbell, Alan Wise

Molecular Cancer Therapeutics, 22(12_Supplement), B055 · Published 1 December 2023 · DOI 10.1158/1535-7163.targ-23-b055

View at the publisherCite this paper

In brief

“Abstract B055: Characterization of highly selective and CNS-penetrant PARP1 inhibitors” is a 2023 journal article by Phillip M. Cowley and 3 co-authors, published in Molecular Cancer Therapeutics. OpenAlex counts 0 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
Authors
4

Abstract

First-generation PARP1/2 inhibitors are FDA-approved for cancers such as breast, ovarian prostate and pancreas and provide significant therapeutic benefit to patients whose tumors harbor BRCA1 or BRCA2 mutations or homologous recombination deficiency (HRD). However, their use is associated with hematological toxicities that narrow their therapeutic index and restrict their application, particularly in combination with standard-of-care… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Cowley, P. M., McGuinness, B. E., Campbell, G. M., & Wise, A. (2023). Abstract B055: Characterization of highly selective and CNS-penetrant PARP1 inhibitors. Molecular Cancer Therapeutics, 22(12_Supplement), B055. https://doi.org/10.1158/1535-7163.targ-23-b055

MLA 9

Cowley, Phillip M., et al. “Abstract B055: Characterization of highly selective and CNS-penetrant PARP1 inhibitors.” Molecular Cancer Therapeutics, vol. 22, no. 12_Supplement, 2023, p. B055. https://doi.org/10.1158/1535-7163.targ-23-b055.

Chicago

Cowley, Phillip M., Barry E. McGuinness, Gillian M. Campbell, and Alan Wise. 2023. “Abstract B055: Characterization of highly selective and CNS-penetrant PARP1 inhibitors.” Molecular Cancer Therapeutics 22 (12_Supplement): B055. https://doi.org/10.1158/1535-7163.targ-23-b055.

Harvard

Cowley, P. M. et al. (2023) ‘Abstract B055: Characterization of highly selective and CNS-penetrant PARP1 inhibitors’, Molecular Cancer Therapeutics, 22(12_Supplement), p. B055. doi:10.1158/1535-7163.targ-23-b055.

IEEE

P. M. Cowley, B. E. McGuinness, G. M. Campbell, and A. Wise, “Abstract B055: Characterization of highly selective and CNS-penetrant PARP1 inhibitors,” Molecular Cancer Therapeutics, vol. 22, no. 12_Supplement, p. B055, 2023, doi: 10.1158/1535-7163.targ-23-b055.

BibTeX

@article{cowley2023abstract,
  title     = {{Abstract B055: Characterization of highly selective and CNS-penetrant PARP1 inhibitors}},
  author    = {Cowley, Phillip M. and McGuinness, Barry E. and Campbell, Gillian M. and Wise, Alan},
  journal   = {Molecular Cancer Therapeutics},
  year      = {2023},
  volume    = {22},
  number    = {12_Supplement},
  pages     = {B055},
  doi       = {10.1158/1535-7163.targ-23-b055},
  url       = {https://doi.org/10.1158/1535-7163.targ-23-b055}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy

  • PARP-1 inhibitors
  • hematologic toxicity
  • homologous recombination deficiency
  • ATR inhibitors
  • ATM deficiency
  • CNS penetration
  • poly(ADP-ribosyl)ation
  • PK/PD relationship

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Cowley, P. M., McGuinness, B. E., Campbell, G. M., & Wise, A. (2023). Abstract B055: Characterization of highly selective and CNS-penetrant PARP1 inhibitors. Molecular Cancer Therapeutics, 22(12_Supplement), B055. https://doi.org/10.1158/1535-7163.targ-23-b055

How many times has this paper been cited?

0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Phillip M. Cowley, Barry E. McGuinness, Gillian M. Campbell, Alan Wise.

What is the DOI of this paper?

10.1158/1535-7163.targ-23-b055, permanently at https://doi.org/10.1158/1535-7163.targ-23-b055. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.